Name: 10th World Congress on Neurology and Therapeutics
Start: 2024-11-21
End: 2024-11-23
Location: Dubai

Conference Information

Welcome Message

Dear Prestigious Participants and Honored Guests,

We are delighted to welcome you to the 10th World Congress on neurology and Therapeutics, set to take place from, November 21-22, 2024. This global event will be hosted at UAE in Dubai, bringing together experts from around the world in the field of neurology.

This conference is a remarkable opportunity for professionals, scholars, and practitioners to convene, exchange insights, and share their knowledge on various aspects of neurology. We are truly honored to have such a distinguished group of participants, and we eagerly anticipate the enriching discussions and collaborative growth that will unfold.

Themed "Neurological Innovations: Emerging Research and Therapeutic Strategies," the congress will provide a platform for in-depth exploration and dialogue on contemporary issues and innovations that are shaping the future of Neurological science and practice.

We deeply appreciate your involvement and the valuable contributions you will bring to this event. We look forward to engaging with you in thought-provoking sessions, insightful presentations, and productive networking opportunities throughout the conference.

Once again, welcome to the World Congress on neurology. We hope you find the conference both rewarding and inspiring.

Warm Regards,

Ellie Rebecca
Programme Manager | Neurology 2024
Email : neurology@pulsusforums.com
Whatsapp: +447389644903

About Conference

The Pulsus Group is committed to enhancing exposure for our attendees by bringing together a diverse array of professionals from both academia and industry. This includes Neurologists, Neurosurgeons, Scientists, Neurosurgery Researchers, Academic Scientists, and Diagnostic Laboratory Professionals. This diversity makes Neurology 2024 an exceptional platform for interdisciplinary engagement.

Neurology 2024 will be organized under the theme " Neurological Innovations: Emerging Research and Therapeutic Strategies." Our goal is to offer a comprehensive curriculum that covers the full spectrum of research and advancements in Neurology and Therapeutics. We aim to facilitate the exchange of cross-cultural experiences related to various treatment options and rehabilitation techniques.

The conference will highlight world-class keynote lectures, speaker sessions, workshops, and a Young Researcher’s Forum, focusing on high-tech advancements and cutting-edge research on a global scale. It will also showcase innovative tools for effective disease treatment, positioning this event as the premier venue to learn about current research and emerging breakthroughs in Neurology.

Neurology 2024 Highlights:

200+ Participants
10+ Keynote Speakers
25+ Plenary Speakers
5+ Exhibitors
15 Innovative Educational Sessions
B2B Meetings

We look forward to your participation in what promises to be an enlightening and impactful gathering.

Neurology 2024 offers a distinctive platform for discussing and exploring the latest advancements in the field of Neurology. This gathering provides a unique opportunity for researchers and practitioners to converge and delve into the most current developments in Neurology and Therapeutics. Attendees will benefit from intimate settings conducive to in-depth discussions, where scientists and medical professionals can exchange innovative ideas, review recent discoveries, and plan collaborative projects.

By participating in Neurology 2024, you will have access to:

Engaging Dialogues: Interact with leading experts and thought leaders through dynamic keynote presentations and panel discussions.
Innovative Techniques: Explore cutting-edge techniques and methodologies that are shaping the future of Neurology.
Current Trends: Gain insights into the latest research, trends, and breakthroughs in Neurology, Neuroscience, Mental Health, Psychiatry, and Neurological Disorders.
Networking Opportunities: Build meaningful connections with peers, potential collaborators, and industry leaders in a collaborative environment.

This conference is an ideal venue to stay at the forefront of your field, engage with emerging research, and contribute to the ongoing evolution of Neurology and Therapeutics.

Neuroscientists

Neurosurgeons
Health Organizations
Pharmaceutical Companies and Industries
Medical Device Manufacturers

Join us at Neurology 2024 to be part of this premier event and contribute to the advancement of Neurological science. We look forward to your participation and the shared success of this event.

Target Audience:

Directors and Executives
Psychiatrists
Academics and Scholars
Neurology Researchers
Clinical Neurologist
Chiropractors
Neuropsychologists
Neuroscientists
Neurosurgeons
Healthcare Organizations
Pharmaceutical and Biotech Companies
Medical Device Manufacturers

Top universities around the globe

Harvard University-United States
University College of London-United States
Johns Hopkins University-United States
University of California, Los Angeles-United States
University of Oxword-United Kingdom
University of Toronto-Canada
McGill University-Canada
University of Pennsylvania-US
Karolinska Institue-Swedan
University of Melbourne-Austraila
University of Zurich-Switzerland
Sapienza University of Rome-Italy
Grenoble Alpes University-France
University of Tubingen-Germany
University of British Columbia - Canada

Major Neurology Associations around the World

American Neurological Association(ANA)
World federation of Neurology
Society for Neuroscience
Neurological Society of India
International Neuroscience Organizations
Child Neurology Society
European Federation of Neurological societies

Major Hospitals around the World

NYU Langone Hospitals
New York – Presbtyterian Hospital- Columbia and Cornell
Johns Hopkins Hospital
Massachusetts General Hospital
Mayo Clinic- Rochester

Top Companies around the World

Pfizer
Abbott
Tonix Pharmaceuticals
Bristol Myers Squibb
Astra Zeneca
Stryker
Amgen
Abbvie

Abstract Submission

Neurology 2024 is pleased to invite submissions of abstracts showcasing original research in the following scientific areas:

ABSTRACT SUBMISSION GUIDELINES

Do you have cutting-edge research poised to advance the field of neurology? We invite you to submit your innovative proposals for papers and posters to the neurology 2024. Share your breakthroughs and join a global network dedicated to pushing the boundaries of Neurological science.

Abstract Acceptance Criteria

Your submission will be assessed based on these criteria.

Themed Alignment: Does your research align with the conference's core topics, such as novel treatments, diagnostic advancements, or rehabilitation strategies? (For details, visit neurology 2024)

Presentation Quality: Is your abstract well-organized, clear and succinct, effectively communicating the essence of your work?

Methodological Rigor (Research Studies): Does your proposal demonstrate a solid research design with clearly defined research questions, methods for data collection, analysis strategies, and anticipated outcomes?

Clinical Relevance: Is your topic pertinent to improving clinical practice and patient outcomes in neurology?

Integration of Research & Practice: Does your research bridge theoretical concepts with practical applications, offering valuable insights for clinicians and patients?

Originality and Innovation: Does your proposal offer new perspectives or innovative approaches that could significantly influence the field of neurology?

Submissions meeting these criteria are more likely to be selected for presentation at the conference. We encourage proposals that foster new discussions and drive advancements in neurology.

REVIEW PROCESS OVERVIEW

Neurology 2024 is committed to a transparent and efficient review process adhering to international standards. We utilize a global network of esteemed neurology specialists to ensure a thorough and unbiased evaluation of your submission.

Key Features:

Rapid Feedback: Expect to receive review results within 48 hours of submission, enabling prompt planning for next steps.

Double-Blind Review: Your abstract will be evaluated anonymously by at least two qualified neurology specialists to minimize bias and focus on the scientific merit of your research.

Constructive Feedback: Acceptance or rejection notifications will include detailed feedback from reviewers, offering valuable guidance for improving your manuscript or poster.

Streamlined Revisions: If revisions are required, feedback will be provided within 24 hours. We recognize the complexity of some revisions and will consider extension requests on a case-by-case basis.

Final Decision: The neurology 2024 Scientific Committee Chair will make the final decision on abstracts, ensuring a thorough and balanced evaluation.

Our commitment to this efficient review process ensures the presentation of groundbreaking research and advancements in neurology at neurology 2024.

CONTENT AND STRUCTURE

Session Selection: Select the most appropriate session from the Scientific Sessions list for your research.

Reference Template: Use the provided Reference template for consistent citations.

Word Limit: Limit your abstract to 300 words, ensuring it remains clear and informative.

Relevance: Ensure your abstract aligns with one or more conference themes or topics.

Author Information: Clearly list the affiliation and institution (university/hospital/organization) of each author.

Abstract Structure: Organize your abstract into clear sections:

Abstract
Introduction
Methods
Results
Discussion
Conclusions
Acknowledgements (if applicable)
References

Short Biography Provide a short biography (up to 150 words) for each author, including a photo and email address.

PRESENTER REQUIREMENT

Registration: All presenting authors must register for the conference and attend their designated presentation session.

Single Submission: Each presenter may submit only one abstract as the lead author. Exceptions may be considered for collaborative work with community organizations.

Review Process:

Neurology 2024 review committee reserves the right to reassign abstracts if they significantly deviate from the selected topic area.

SUBISSION GUIDELINES

To ensure a smooth submission process and contribute to the conference’s success, follow these steps:

Submission Platform: Submit your abstract electronically as a Word document through our online submission system. [Visit neurology 2024- abstract submission]

Presentation Category: Choose the relevant category for your presentation: Oral, Poster, or Young Investigator Award (if applicable).

Key components of Neurological Rehabilation

Physical Therapy
Occupational Therapy
Speech and Language Therapy
Cognitive Rehabilation
Neuropsychological Therapy
Vocational Rehabilation
Multidisciplinary Team Approach

Deadlines

Highlighted dates for Neurology 2024:

Abstract Submission Opens: August 1, 2024.
Early Bird Deadline for Abstract Submission: September 15, 2024.
Early Bird Deadline for paper Submission: September 15, 2024.
Regular Deadline for Abstract Submission: October 18, 2024.
Late Submission Deadline (with late fee): November 21, 2024.
Notification of Acceptance: Within 24 hours.
Final Submission of Accepted Abstracts: November 21, 2024.

Group Registration

Enhance your expertise in Neurology 2024 at this premier event. Take advantage of our group registration offer: register a group of 5 or more and receive a 10% discount on the total registration fee!

Sign up now to take advantage of exclusive early bird benefits! For further information, please check out the Neurology 2024.

Don’t miss out on this chance to enhance your knowledge, connect with peers, and advance your practice through group and early bird savings. We eagerly anticipate the opportunity to host you and your team in Dubai for a valuable and engaging event!

Scientific Sessions

The core focus of this session is the intricate study of the brain and nervous system, addressing various aspects of neuronal function, diagnostic techniques, treatments, and disorders. Our neurology conference will delve into the mechanisms of normal brain function, the challenges of diagnosing neurological conditions, and the latest advancements in treatment.

Expert neurologists will share insights on managing these complex conditions, discussing advancements in cerebrovascular treatments, spinal cord interventions, and overall neurological care. This session is designed to offer in-depth knowledge and facilitate discussions on cutting-edge research and clinical practices in neurology.

Session 1: Neurology

This session will provide a broad overview of current issues and advancements in neurology. Participants will discuss recent research findings, clinical practices, and emerging trends in the field. The session aims to update attendees on significant developments in understanding neurological functions, diagnosing disorders, and implementing effective treatments.

1-1: Fundamentals of Neurology

1-2: Emerging Diagnostic Tools

1-3: Innovative Treatment Approaches

1-4: Neurological Disorders Overview

1-5: Clinical Best Practices

1-6: Future Directions in Neurology

Related Conference

Neurology 2024 | Neurology 2024 Conference | Global Neurotechnology Summit | International Conference on Neurodegenerative Diseases | World Congress on Brain and Cognitive Sciences | Innovations in Epilepsy Conference | Global Symposium on Stroke Research and Management | International Neuroimmunology and Neuroinflammation Conference | Advanced Neurorehabilitation Technologies Forum | Neurogenomics and Personalized Medicine Conference | World Forum on Pediatric Neurology | Cutting-Edge Neuroplasticity and Rehabilitation Summit.

Related Association

International Society for Neurovascular Disease (ISNVD) | Brain & Behavior Research Foundation (BBRF) | International Headache Society (IHS) | American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) | International Multiple Sclerosis Society (IMSS) | International Society for Pediatric Neurosurgery (ISPN) | Neuro-Oncology Society (NOS) | Society of NeuroInterventional Surgery (SNIS) | International Society for the Study of Pain (IASP) | European Society of Neurosonology and Cerebral Hemodynamics (ESNCH).

Associated Journals

Associated Societies

International Society for Neurogenetics (ISN) | International Society for Neuroethology (ISN)| American Society of Neuroimaging (ASN) | International Society for Research in Neurodevelopmental Disabilities (ISRNDD) | European Society of Neurosonology and Cerebral Hemodynamics (ESNCH) | Neuropsychological Society (NPS) | Society for Neuro-Oncology (SNO) | International Society for Neurotrauma and Critical Care (ISNCC) | International Headache Society (IHS) | American Association of Neurological Surgeons (AANS) | European Society for the Study of Tourette Syndrome (ESSTS) | International Society of Behavioral Neurology and Neuropsychiatry (ISBNNP) | Neuroplasticity Society (NPS) | Neuroimmunology Research Society (NIRS) | Global Stroke Alliance (GSA).

Session 2: Neurostimulation

Focus on the applications and advancements in neurostimulation technologies used to treat neurological and psychiatric conditions. The session will cover various techniques, including deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), and spinal cord stimulation (SCS). Discussions will explore the mechanisms behind these therapies, their clinical efficacy, and emerging innovations in neurostimulation.

2-1: Introduction to Neurostimulation

2-2: Innovative Neurostimulation Technologies

2-3: Clinical Applications and Efficacy

2-4: Integration into Clinical Practice

2-5: Future Directions and Innovations

2-6: Ethical Considerations and Patient Perspectives

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 3: Neurogenesis

Delve into the process of neurogenesis, where new neurons are formed in the brain. This session will explore the biological mechanisms that drive neurogenesis, its role in brain development and repair, and its implications for treating neurological conditions. Topics will include the impact of neurogenesis on cognitive function, recovery from injury, and potential therapeutic applications.

3-1: Fundamentals of Neurogenesis

3-2: Neurogenesis in Health and Disease

3-3: Influencing Factors and Environmental Impact

3-4: Therapeutic Potential

3-5: Research and Clinical Innovations

3-6: Practical Applications

Related Conference

Related Association

Associated Journals

Associated Societies

Session 4: Neurophysiology

Examine the physiological processes that underpin neural function in this detailed session. Discussions will focus on how neural circuits operate, the role of neurotransmitters, and the physiological changes associated with various neurological conditions. Participants will explore methods for studying neural activity and how these insights contribute to understanding brain function and disease.

4-1: Fundamental Principles of Neurophysiology

4-2: Electrophysiological Techniques

4-3: Neurophysiological Correlates of Neurological Disorders

4-4: Neuroplasticity and Functional Reorganization

4-5: Neurophysiology in Clinical Practice

4-6: Innovations and Future Directions

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 5: Neurotherapeutics and Neuropharmacology

This session will delve into the development and application of pharmacological treatments for neurological conditions. It will cover the latest advancements in drug discovery, including novel neuropharmacological agents, their mechanisms of action, and their clinical efficacy. Participants will explore innovative therapies aimed at enhancing patient outcomes in various neurological disorders, along with discussions on personalized medicine approaches and emerging trends in neurotherapeutics.

5-1: Innovative Drug Therapies

5-2: Emerging Pharmacological Agents

5-3: Clinical Trial Insights

5-4: Therapeutic Strategies

5-5: Pharmacokinetics and Pharmacodynamics

5-6: Patient-Centered Care

Related Conference

Related Association

Associated Journals

Associated Societies

Session 6: Neurological Disorders and Neurodegenerative Diseases

This comprehensive session will address a spectrum of neurological disorders, including chronic and progressive neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. Discussions will focus on the latest research on disease pathogenesis, advancements in diagnostic techniques, and the development of new therapeutic strategies. The session will also explore the impact of these diseases on patients and their families, and the ongoing efforts to improve treatment and management.

6-1: Neurological Disorders Overview

6-2: Neurodegenerative Diseases Focus

6-3: Diagnostic Innovations

6-4: Therapeutic Strategies

6-5: Case Studies and Best Practices

6-6: Future Directions and Research

Related Conference

Related Association

Associated Journals

Associated Societies

Session 7: Neuromuscular Disorders

Explore the complexities of neuromuscular disorders, which affect the communication between nerves and muscles. This session will provide insights into conditions such as muscular dystrophy, myasthenia gravis, and amyotrophic lateral sclerosis (ALS). Topics will include current diagnostic methods, treatment advancements, and ongoing research aimed at improving the quality of life for patients with these challenging conditions.

7-1: Overview of Neuromuscular Disorders

7-2: Diagnostic Innovations

7-3: Treatment and Management Strategies

7-4: Case Studies and Practical Applications

7-5: Research and Future Directions

7-6: Multidisciplinary Collaboration

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 8: Clinical Neurology

A Practical session dedicated to clinical neurology, focusing on the diagnosis and management of neurological conditions. This session will include case studies, discussions on clinical techniques, and updates on best practices. Participants will gain insights into effective patient care strategies and the integration of new research findings into clinical practice.

8-1: Diagnostic Approaches in Clinical Neurology

8-2: Management Strategies for Neurological Disorders

8-3: Case Studies and Clinical Scenarios

8-4: Innovative Therapeutic Techniques

8-5: Patient-Centered Care and Communication

8-6: Interdisciplinary Collaboration and Ethical and Legal Considerations

Related Conference

Related Association

Associated Journals

Associated Societies

Session 9: Neurological Nursing

This session will highlight the specialized role of nursing in managing patients with neurological disorders. Topics will include advanced nursing practices, patient care strategies, and the challenges faced by neurological nurses. The session will also cover innovative approaches to nursing care and the importance of interdisciplinary collaboration in optimizing patient outcomes.

9-1: Comprehensive Care for Neurological Patients

9-2: Advanced Clinical Skills

9-3: Innovations in Neurological Nursing

9-4: Patient Education and Support

9-5: Multidisciplinary Collaboration and Ethical and Legal Considerations

9-6: Challenges and Solutions in Neurological Nursing

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session10: Neuropediatrics

Neuropediatrics is a specialized branch of pediatrics that focuses on the diagnosis and treatment of neurological disorders in children. This field combines aspects of neurology, developmental medicine, and pediatric care to address a wide range of conditions affecting the nervous system in infants, children, and adolescents.

10-1: Pediatric Neurological Disorders

10-2: Early Diagnosis and Intervention

10-3: Neurodevelopmental Disorders and Multidisciplinary Care

10-4: Neurogenetic and Metabolic Disorders

10-5: Management of Pediatric Seizure Disorders

10-6: Psychosocial Aspects of Pediatric Neurology

Related Conference

Related Association

Associated Journals

Associated Societies

Session11: Neuroimmunology

Explore the intersection of neurology and immunology in this session. Discussions will center on autoimmune neurological diseases, neuroinflammation, and the role of the immune system in neurological disorders. Participants will learn about emerging treatments that target immune system dysfunctions and how these therapies are reshaping the management of neurological diseases.

11-1: Immune System and Neurological Disorders

11-2: Neuroinflammation & Clinical Case Studies

11-3: Autoimmune Neurological Diseases

11-4: Immune Modulation and Therapy

11-5: Neuroimmunological Biomarkers & Innovations in Neuroimmunology Research

11-6: Blood-Brain Barrier and Immune Function

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 12: Neurosurgery

This session will cover advancements in neurosurgical techniques and their application in treating neurological conditions. Topics will include the latest surgical innovations, patient outcomes, and case studies highlighting complex neurosurgical procedures. Participants will gain insights into how neurosurgery is evolving and its impact on patient care.

12-1: Advanced Surgical Techniques

12-2: Neurosurgical Navigation and Imaging

12-3: Brain Tumor Surgery & Neurovascular Surgery

12-4: Spinal Surgery Innovations & Surgical Complications and Risk Management

12-5: Neurotrauma Management & Emerging Technologies and Research

12-6: Functional Neurosurgery

Related Conference

Related Association

Associated Journals

Associated Societies

Session 13: Neural Circuits and Neural Feedback

Delve into the study of neural circuits and the concept of neural feedback in this session. Topics will include the structure and function of neural circuits, their role in behavior and cognition, and how neural feedback mechanisms are used in therapeutic contexts. Discussions will focus on how these circuits influence brain function and how feedback is applied in clinical and research settings.

13-1: Understanding Neural Circuits

13-2: Neural Network Models & Clinical Applications and Therapeutic Approaches

13-3: Functional Connectivity and Mapping

13-4: Neural Feedback Mechanisms & Ethical Considerations and Future Directions

13-5: Rain-Computer Interfaces (BCIs)

13-6: Neuroplasticity and Circuit Remodeling

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 14: Neuroplasticity

Explore the brain's remarkable ability to adapt and reorganize itself through neuroplasticity. This session will cover how neuroplasticity contributes to learning, recovery from neurological injuries, and rehabilitation. Participants will discuss the implications of neuroplasticity for developing new therapies and enhancing brain function.

14-1: Fundamentals of Neuroplasticity

14-2: Mechanisms of Neuroplasticity & Technological Advances

14-3: Neuroplasticity Across the Lifespan

14-4: Plasticity and Learning & Challenges and Future Directions

14-5: Rehabilitation and Recovery & Clinical Applications and Therapeutic Approaches

14-6: Neuroplasticity in Neurodegenerative Diseases

Related Conference

Related Association

Associated Journals

Associated Societies

Session 15: Neuroimaging and Radiology

Examine the latest advancements in neuroimaging technologies, including MRI, CT scans, and other radiological methods used to diagnose and monitor neurological conditions. This session will focus on how imaging techniques are improving diagnostic accuracy, treatment planning, and research into brain and nervous system disorders.

15-1: Fundamentals of Neuroimaging

15-2: Advancements in Imaging Technologies

15-3: Neuroimaging in Neurological Disorders

15-4: Radiological Techniques and Protocols

15-5: Functional and Molecular Imaging & b Emerging Trends and Research

15-6: Neuroimaging in Neurosurgical Planning & Clinical Case Discussions

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 16: Psychology and Psychiatry

Investigate the interplay between neurology, psychology, and psychiatry in this session. Topics will include how neurological conditions impact mental health and the integration of psychiatric approaches into neurological care. Discussions will focus on mental health interventions and their effects on neurological conditions.

16-1: Foundations of Psychology and Psychiatry

16-2: Psychiatric Disorders in Neurology

16-3: Neuropsychological Assessment & Integration of Psychiatry in Neurological Practice

16-4: Psychopharmacology & Impact of Psychological Factors on Neurological Outcomes

16-5: Therapeutic Approaches and Psychotherapy & Current Research and Future Directions

16-6: Behavioral Neurology and Neuropsychiatry

Related Conference

Related Association

Associated Journals

Associated Societies

Session 17: Behavioral Sciences

Explore how behavioral science intersects with neurology, focusing on research related to behavior, cognition, and the impact of neurological disorders on behavior. This session will cover studies on behavioral interventions, cognitive function, and the relationship between neurological health and behavior.

17-1: Foundations of Behavioral Sciences

17-2: Behavioral Assessments and Interventions

17-3: Neurobehavioral Disorders & Neuropsychological Rehabilitation

17-4: Cognitive Behavioral Therapy (CBT) and Other Therapeutic Approaches

17-5: The Role of Environmental and Social Factors

17-6: Behavioral Neurology & Case Studies and Practical Applications

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 18: Clinical Trials, Case Studies, and Recent Research

Present and discuss recent findings from clinical trials, case studies, and ongoing research in neurology. This session will highlight new insights, experimental therapies, and their implications for clinical practice. Participants will gain a comprehensive overview of cutting-edge research and its potential impact on the field of neurology.

18-1: Overview of Recent Clinical Trials

18-2: Innovative Research Developments

18-3: Case Studies in Neurology & Challenges and Solutions in Clinical Research

18-4: Translational Research & Future Directions in Neurological Research

18-5: Ethical Considerations in Clinical Trials

18-6: Emerging Technologies and Tools

Related Conference

Related Association

Associated Journals

Associated Societies

Session 19: Neurophysiology and Brain Function:

Neurophysiology and Brain Function is a field dedicated to understanding the intricate workings of the brain and nervous system at a physiological level. It explores how neurons communicate through electrical impulses and chemical signals, examining the fundamental processes of neurotransmission and synaptic plasticity. This discipline employs advanced imaging techniques, such as functional MRI (fMRI) and electroencephalography (EEG), to visualize and analyze brain activity in real time, revealing how different brain regions interact and respond to stimuli. Research in neurophysiology also delves into neuroplasticity, the brain's remarkable ability to reorganize itself by forming new neural connections, which is crucial for learning, memory, and recovery from injury.

19-1: Neuronal Communication

19-2: Brain Activity and Imaging

19-3: Pathophysiology of Neurological Disorders

19-4: Brain Rhythms and Oscillations

19-5: Innovations in Electrophysiological Monitoring

19-6: Neuroplasticity and Functional Recovery.

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 20: Brain imaging and Diagnostics

Brain Imaging and Diagnostics focuses on advanced techniques used to visualize and assess brain structure and function. This field utilizes tools like functional MRI (fMRI), which tracks real-time brain activity by measuring blood flow, and electroencephalography (EEG), which records electrical activity from the scalp. These imaging methods provide insights into brain connectivity, identify abnormalities, and monitor disease progression. Additionally, techniques such as positron emission tomography (PET) and computed tomography (CT) scans offer detailed images of brain anatomy and help diagnose various Neurological conditions. Innovations in brain imaging continue to enhance our understanding of cognitive functions, detect early signs of Neurological disorders, and guide therapeutic interventions. By integrating these diagnostic tools, clinicians and researchers can better evaluate brain health and develop targeted treatment strategies.

20-1: Advanced MRI Techniques

20-2: Biomarkers for Early Diagnosis of Neurological Disorders

20-3: Computed Tomography (CT) for Neurological Disorders

20-4: Functional MRI (fMRI) Applications

20-5: Electroencephalography (EEG) Insights

20-6: Positron Emission Tomography (PET) Imaging

Related Conference

Related Association

Associated Journals

Associated Societies

Session 21: Neurointervention Advances

Neurointervention Advances focus on the evolving techniques and technologies used to treat Neurological conditions through minimally invasive procedures. This field includes the development of advanced catheter-based procedures for addressing cerebrovascular disorders, such as aneurysms and arteriovenous malformations. Recent innovations involve the use of neurovascular stents, coil embolization, and mechanical thrombectomy to manage stroke and improve patient outcomes. Additionally, advancements in image-guided surgery enhance precision in targeting and treating brain tumors and lesions. Techniques such as neuroendoscopy allow for direct visualization and intervention within the brain's ventricles and other critical areas. The integration of robotics and real-time imaging further refines these procedures, making them safer and more effective. Neurointervention continues to expand with novel approaches, including drug delivery systems and gene therapy, offering new hope for previously challenging conditions.

21-1: Endovascular Techniques for Aneurysm Treatment

21-2: Mechanical Thrombectomy Innovations

21-3: Neurovascular Stenting

21-4: Image-Guided Brain Tumor Resection

21-5: Neuroendoscopic Procedures

21-6: Advanced Coil Embolization Techniques

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 22: Gene and Cell Therapy

Gene and Cell Therapy focuses on innovative treatments aimed at correcting genetic defects and repairing damaged cells to address Neurological disorders. This field includes gene editing techniques like CRISPR-Cas9, which are used to target and modify faulty genes associated with conditions such as Huntington’s disease and spinal muscular atrophy. Gene therapy also involves delivering therapeutic genes into patients' cells to produce missing or dysfunctional proteins.

Cell therapy, on the other hand, utilizes stem cells to regenerate damaged brain tissue and restore lost functions in diseases like Parkinson’s disease and multiple sclerosis. Advances in stem cell technology, such as induced pluripotent stem cells (iPSCs), are enabling the development of personalized treatment approaches.

22-1: Gene Editing Techniques in neurology: Current Applications.

22-2: Stem Cell Therapy for Neurological Regeneration

22-3: CRISPR-Cas9 Gene Editing

22-4: Induced Pluripotent Stem Cells (iPSCs) Applications

22-5: Combination Therapies in Neurodegenerative Diseases

22-6: Safety and Efficacy of Gene and Cell Therapies

Related Conference

Related Association

Associated Journals

Associated Societies

Session 23: Neuromodulation Techniques

Neuromodulation Techniques involve using various methods to alter nerve activity and treat Neurological and psychiatric disorders. These techniques adjust brain function through electrical, magnetic, or chemical means to influence mood, cognition, and pain perception. Common neuromodulation methods include Transcranial Magnetic Stimulation (TMS), which uses magnetic fields to stimulate nerve cells, and Deep Brain Stimulation (DBS), which involves implanting electrodes to modulate brain circuits. Vagus Nerve Stimulation (VNS) is another approach where electrical impulses are delivered to the vagus nerve to impact brain activity. Additionally, responsive neurostimulation systems offer real-time adjustments based on brain activity patterns.

23-1: Advancements in Transcranial Magnetic Stimulation (TMS)

23-2: Deep Brain Stimulation (DBS): Innovations and Outcomes.

23-3: Vagus Nerve Stimulation (VNS)

23-4: Responsive Neurostimulation Systems

23-5: Neuromodulation for Depression

23-6: Neuromodulation in Chronic Pain Management

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 24: Neurogenetics and Genomics

Neurogenetics and Genomics focus on understanding the genetic and genomic basis of Neurological disorders and brain function. This field explores how genetic variations and mutations influence the development, progression, and treatment of Neurological conditions. Advances in genomic technologies, such as next-generation sequencing (NGS), have enabled detailed analysis of the human genome, leading to discoveries of genetic markers associated with diseases like Alzheimer's, Parkinson's, and autism spectrum disorders. Neurogenetics research investigates how specific genes and their interactions contribute to brain structure and function.

24-1: Genomic Insights into Complex Neurological Disorders

24-2: Role of Epigenetics in Neurological Diseases

24-3: Next-Generation Sequencing (NGS) Applications

24-4: Gene-Environment Interactions

24-5: Functional Genomics in Brain Research

24-6: Personalized Medicine in Neurogenetics

Related Conference

Related Association

Associated Journals

Associated Societies

Session 25: Neuro-oncology

Neuro-oncology focuses on the study and treatment of tumors affecting the brain and central nervous system. This field encompasses the diagnosis, management, and research of primary brain tumors, such as gliomas, as well as secondary or metastatic tumors that originate elsewhere in the body. Advances in neuro-oncology include developments in imaging technologies for accurate tumor localization and characterization, as well as novel therapeutic approaches such as targeted therapies, immunotherapy, and personalized medicine. Research in this area also involves understanding tumor biology, genetic mutations, and the tumor microenvironment to improve treatment efficacy and patient outcomes.

25-1: Innovative Therapies for Brain Tumors: From Bench to Bedside

25-2: Molecular Markers in Neuro-oncology: Diagnostic and Prognostic Implications

25-3: Immunotherapy for Brain Tumors

25-4: Genetic and Molecular Profiling of Tumors

25-5: Challenges in Metastatic Brain Tumors

25-6: Multidisciplinary Approaches in Tumor Management

Related Conference

Related Associations:

Associated Journals:

Associated Societies:

Session 26: Neurorehabilitation

Neurorehabilitation focuses on the recovery and improvement of function in individuals with Neurological impairments caused by injury, stroke, or degenerative diseases. This field encompasses a range of therapies aimed at restoring lost abilities and enhancing the quality of life for patients with conditions such as stroke, traumatic brain injury, and multiple sclerosis. Advances in neurorehabilitation include the development of personalized rehabilitation programs, utilization of cutting-edge technologies such as robotic-assisted therapy and virtual reality, and integration of neuroplasticity principles to support brain recovery. Multidisciplinary approaches often involve physical therapists, occupational therapists, speech therapists, and neuropsychologists working together to address various aspects of rehabilitation.

26-1: Advancements in Neurorehabilitation Techniques

26-2: Virtual Reality and Robotics in Neurological Rehabilitation

26-3: Virtual Reality for Stroke Rehabilitation

26-4: Principles of Neuroplasticity in Recovery

26-5: Advances in Cognitive Rehabilitation

26-6: Multidisciplinary Approaches to Neurorehabilitation

Related Conference

Related Association

Associated Journals

Associated Societies

Market Analysis

The neurology sector is on track for significant growth through 2024, driven by a combination of increasing disease prevalence, technological innovations, and substantial research investments. Despite challenges such as high costs and regulatory hurdles, ongoing advancements and expanding healthcare infrastructure are likely to create new opportunities and drive market development.

The market was valued at USD 1.2 billion in 2020 and increased to USD 2.4 billion by 2022. In 2023, the global neurology market was valued at roughly USD 3.32 billion and is projected to grow to approximately USD 6.42 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.60% over the forecast period.

MARKET DYNAMICS

Rising cases of Neurological disorders, including Alzheimer's and Parkinson's diseases, are contributing to market growth. The prevalence of these conditions is increasing due to aging demographics, improved diagnostic techniques, and potentially genetic factors. For example, Parkinson’s disease affects nearly 90,000 people annually in the U.S., as reported by the Parkinson’s Foundation in 2022.

Similarly, neurostimulation devices are gaining traction for treating chronic pain and various Neurological disorders by modulating brain activity.

The World Health Organization's 2023 report highlights that epilepsy, affecting approximately 50 million people globally, is a significant driver for the neurology devices market.

Government support, such as research funding from institutions like the National Institute of Neurological Disorders and Stroke (NINDS), is also contributing to market growth. However, challenges like the high cost of devices and a shortage of skilled professionals could hinder market expansion.

SEGMENTAL OVERVIEW

The neurology devices market is divided into product, condition, and end-user categories. Product-wise, it includes neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. By condition, it covers stroke, seizures, hydrocephalus, oncology, and more. End users are categorized into hospitals, ambulatory surgery centers, and other facilities.

Regionally, the market spans North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, rest of LAMEA).

In 2021, interventional neurology devices held the largest market share and are expected to maintain dominance due to their accuracy and endorsement by health authorities. The neurosurgery devices segment is anticipated to grow the fastest, driven by its popularity among doctors and patients due to shorter recovery times.

COMPETITION ANALYSIS

The neurology devices market features major players such as Integra Lifesciences, B.Braun SE, Medtronic plc, Natus Medical Inc, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, Zimmer Biomet Holding Inc., and Johnson & Johnson. These companies utilize strategies like acquisitions, product launches, and approvals to enhance their market presence.

Key product approvals include:

Boston Scientific's Vercise Neural Navigator with STIMVIEW XT received FDA approval in April 2022.
The FDA approved Boston Scientific’s fourth-generation Vercise Genus Deep Brain Stimulation System in January 2021.
Medtronic’s Vanta, a high-performance recharge-free neurostimulator, received FDA approval in June 2021.

Notable product launches include:

Medtronic's advanced Patient Programmer technology for Deep Brain Stimulation debuted in October 2019.
Boston Scientific's WaveWriter Alpha Spinal Cord Stimulator systems were released in January 2021.
Boston Scientific introduced the Vercise Primary Cell and Vercise Gevia Deep Brain Stimulation Systems in January 2019.
LivaNova launched the SenTiva DUO implantable pulse generator in February 2023, featuring a dual-pin header for enhanced VNS Therapy in drug-resistant epilepsy.

Visa Support

Are you planning a trip to Dubai? Join us for our upcoming conference!

Concerned about the visa application process?

We offer extensive VISA support to assist with your application. Our services include:

An Official Invitation Letter.
An Official Acceptance Letter for your abstract.
A Visa Covering Letter, ready for use.

Here’s what you need to know:

After you register for the World Conference on neurology 2024, you will receive a Visa Support Letter (the official invitation letter).

The Visa Support Letter will be issued only to individuals accepted to attend the conference. You will receive the Visa Support Letter as a PDF attachment via email. For any questions or to request your Visa Support Letter, please contact us Neurology 2024

Prepare for your trip with confidence, knowing we are here to support your visa needs.

Venue

Enjoy a comfortable and convenient stay with our well-designed accommodations at the Neurology 2024 Conference.

Comfort and Convenience:

Complimentary Breakfast: Start your day with a hearty breakfast included in your room rate.

Seamless Connectivity: Stay connected and network effortlessly with our free Wi-Fi available throughout the conference venue.

Flexible Check-In/Out: Take advantage of early check-in or late check-out options, subject to room availability, to make the most of your time in Dubai.

Room Options:

Single or Double Occupancy: Choose from single rooms for a private retreat or double rooms if you prefer to share your stay with a colleague. We offer various room types to suit your needs.

Additional Assistance:

Booking for Others: If you need to book additional rooms for colleagues or family, please contact our dedicated team at the Neurology 2024 Conference. Provide your desired package and number of nights, and we will provide you with a personalized registration link for a smooth booking experience.

Confirm Your Reservation:

Secure Your Stay: Complete your payment promptly to finalize your reservation. You will receive a confirmation email once your payment is processed, securing your stay.

Explore Our Venue: For more information about the location and amenities, visit the Neurology 2024 website. Our team is ready to assist with any inquiries or booking needs. Contact us at the Neurology 2024 Conference for further support.